Adverse events11

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 11 of 11

Type	Event	Organ system	Group	Affected	At risk	Events
other	Stomatitis	Gastrointestinal disorders	Pralatrexate	48	71	101
other	Neutropenia	Blood and lymphatic system disorders	Pralatrexate	22	71	50
serious	Lung infection	Infections and infestations	Pralatrexate	7	71	8
serious	Platelet count decreased	Investigations	Pralatrexate	10	71	13
serious	Thrombocytopenia	Blood and lymphatic system disorders	Pralatrexate	4	71	4
serious	Stomatitis	Gastrointestinal disorders	Pralatrexate	3	71	3
serious	Pneumonia	Infections and infestations	Pralatrexate	4	71	5
serious	Febrile neutropenia	Blood and lymphatic system disorders	Pralatrexate	3	71	3
serious	Pancytopenia	Blood and lymphatic system disorders	Pralatrexate	2	71	2
serious	Hepatic function abnormal	Hepatobiliary disorders	Pralatrexate	1	71	1
serious	Liver injury	Hepatobiliary disorders	Pralatrexate	1	71	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03349333/events